A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor.
将 Idelalisib 与新型脾酪氨酸激酶 (Syk) 抑制剂 GS-9973 联合使用,有望成为治疗慢性淋巴细胞白血病的潜在疗法
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.1484
Burke Russell T, Meadows Sarah, Loriaux Marc M, Currie Kevin S, Mitchell Scott A, Maciejewski Patricia, Clarke Astrid S, Dipaolo Julie A, Druker Brian J, Lannutti Brian J, Spurgeon Stephen E